JNS Volume Alert - JNS 14.67 Janus Capital Group Inc $JNS

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
JNS Volume Alert - JNS 14.67 Janus Capital Group Inc $JNS Hit a high of 15.06 Currently 11:14 Last price 14.67 -0.51 -3.36% With a day low of 14.58 and a current volume of 1,853,180.

JNS Janus Capital Group Inc Recent Headline News

Janus Benefits on Gross Hire: $1B Client Deposits - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 2:56PM CST
The hiring of champion bond manager, Bill Gross, seems to have benefited the global investment firm Janus Capital Group, Inc. (JNS)
LION: 15.30 (+0.14), OSBC: 4.70 (-0.05), EFSC: 19.04 (+0.12), JNS: 14.57 (-0.61)

Gross' new Janus fund bring in $364M in first full month
Seeking Alpha - at Seeking Alpha - Mon Nov 10, 10:49AM CST

JNS: 14.57 (-0.61)

Post Earnings Update: Janus Capital Has Climbed 5.8% Higher in Past 2 Weeks (JNS)
Comtex SmarTrend(R) - Mon Nov 10, 10:42AM CST
18 days ago, on October 23rd, 2014, Janus Capital (NYSE:JNS) reported its earnings. Analysts, on average, expected earnings of $0.22 per share on sales of $239.3 million. Janus Capital actually reported earnings of $0.22 per share on sales of $237.0 million, beating EPS estimates by $0.00 and missing revenue estimates by $2.3 million. Since the company's report, shares of Janus Capital have risen from $14.47 to $15.31, representing a gain of 5.8% in the past 18 days.
JNS: 14.57 (-0.61)

Bill Gross' Parting Gift to Fund Shareholders: Higher Taxes?
Dan Caplinger, The Motley Fool - Motley Fool - Mon Nov 03, 6:45AM CST
Bill Gross. Source: PIMCO The high-profile departure of Bill Gross from PIMCO to Janus Capital got plenty of headlines. Internal political upheaval at the bond-focused money-management firm finally led the billionaire fund manager to jump...
BOND: 108.88 (-0.11), JNS: 14.57 (-0.61)

Insider Trading Alert - SCSS, JNS And LLTC Traded By Insiders
at The Street - Thu Oct 30, 10:00AM CDT
Stocks with insider trader activity include SCSS, JNS and LLTC
SCSS: 26.55 (+0.16), LLTC: 43.09 (-0.55), JNS: 14.57 (-0.61)

Is WisdomTree Investments Inc. Finally Poised for a Turnaround?
Dan Caplinger, The Motley Fool - Motley Fool - Thu Oct 30, 7:05AM CDT
Source: WisdomTree. Finding smart investments is one of the hardest tasks an investor faces. Sometimes, it pays to invest in the companies that make it their job to provide investment options to millions of investors across the world. WisdomTree...
BLK: 350.68 (-0.02), JNS: 14.57 (-0.61), WETF: 15.94 (+0.30), SCHW: 28.95 (+0.03)

InsiderInsights.com Daily Round Up 10/29/14: JMP, UFI AIRT, COG
InsiderInsights - at Seeking Alpha - Thu Oct 30, 6:25AM CDT

CRS: 51.59 (+0.11), BBY: 34.72 (+0.01), AIRT: 15.71 (+0.05), CB: 101.47 (-0.40), LL: 55.62 (-0.23), SHLD: 37.43 (-1.29), PRTO: 10.07 (-0.02), BIOF: 7.28 (+0.01), CELG: 107.64 (-0.37), UA: 67.97 (-0.37), JMP: 7.82 (-0.03), COG: 33.66 (+0.46), JNS: 14.57 (-0.61), EMC: 29.03 (-0.13), SPLK: 66.71 (-0.05), MSFT: 48.81 (-0.08), DOW: 49.62 (+0.14), UFI: 27.01 (-0.74), CRM: 63.86 (-0.59)

Unconstrained Bond Funds Enjoy Surging Popularity - Mutual Fund Commentary
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 11:37AM CDT
A major reason behind the surging popularity of this category is the low interest rate environment. Low interest rates often lead fixed income seeking investors to buy corporate debts or emerging market sovereign bonds. Unconstrained bonds offer both these.
JNS: 14.57 (-0.61)

Selection as Fiscal Agent, Quarterly Earnings, and Dividend Declaration - Research Reports on U.S. Bancorp, ACE, Discover, Schwab and JCG
PR Newswire - Tue Oct 28, 8:30AM CDT
Today, Analysts Review released its research reports regarding U.S. Bancorp (NYSE: USB), ACE Limited (NYSE: ACE), Discover Financial Services (NYSE: DFS), The Charles Schwab Corporation (NYSE: SCHW) and Janus Capital Group, Inc. (NYSE: JNS). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7495-100free.
DFS: 66.30 (-0.04), ACE: 111.00 (-0.51), USB: 44.02 (+0.09), JNS: 14.57 (-0.61), SCHW: 28.95 (+0.03)

Update: Janus Q3 Earnings Are Just Meh
Marshall Hargrave - at Seeking Alpha - Mon Oct 27, 3:02PM CDT

JNS: 14.57 (-0.61)

Franklin Fiscal Q4 Earnings Beat Estimates on High Revenues - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 8:44AM CDT
Driven by strong revenues, Franklin Resources Inc.'s (BEN) fiscal fourth-quarter 2014 earnings of $1.02 per share significantly beat the Zacks Consensus Estimate of 92 cents.
LAZ: 49.19 (-0.17), JNS: 14.57 (-0.61), LM: 54.37 (+0.09), BEN: 56.86 (+0.29)

Principal Financial Beats on Q3 Earnings as Top Line Grows - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 11:00AM CDT
Principal Financial's (PFG) operating net income of $1.19 per share beat the Zacks Consensus Estimate by about 12% and improved nearly 32% year over year.
BX: 31.66 (-0.04), BLK: 350.68 (-0.02), PFG: 53.36 (+0.10), JNS: 14.57 (-0.61)

Janus Capital Reports In-Line Q3 Earnings, Shares up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 9:45AM CDT
Shares of global investment firm Janus Capital Group, Inc. (JNS) were up 1.4% following the release of its third-quarter 2014 results on Oct 23, before the market opened
IVZ: 41.05 (-0.12), JNS: 14.57 (-0.61), AMP: 130.33 (+0.17), LM: 54.37 (+0.09)

Lazard Q3 Profit Up 44% on Strong M&A Advisory Activity - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 24, 8:02AM CDT
On the back of strong M&A (mergers and acquisitions) advisory activity, Lazard Ltd. (LAZ) beat estimates for the sixth straight quarter.
BX: 31.66 (-0.04), LAZ: 49.19 (-0.17), BLK: 350.68 (-0.02), JNS: 14.57 (-0.61)

Downgrade Alert for Janus Capital (JNS)
Comtex SmarTrend(R) - Fri Oct 24, 7:16AM CDT
Janus Capital (NYSE:JNS) was downgraded from Neutral to Sell at Citigroup today. The stock closed yesterday at $14.47 on volume of 12.6 million shares, above average daily volume of 12.3 million. Janus Capital share prices have moved between a 52-week high of $15.95 and a 52-week low of $9.12 and closed yesterday at 59% above that low price at $14.47 per share. Over the last five market days, the 200-day moving average (MA) has gone up 0.4% while the 50-day MA has advanced 1.7%.
JNS: 14.57 (-0.61)

Janus Capital Group's (JNS) CEO Richard Mac Coy Weil on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 23, 4:20PM CDT

JNS: 14.57 (-0.61)

Janus back to a Sell at Citi
Seeking Alpha - at Seeking Alpha - Thu Oct 23, 1:41PM CDT

JNS: 14.57 (-0.61)

Analysts Grill Janus Capital on 'Bond King' Bill Gross' Impact
at The Street - Thu Oct 23, 11:40AM CDT
Analysts had plenty of questions for Janus Capital Group as they try to gauge the impact over its hire of 'Bond King' Bill Gross.
BLK: 350.68 (-0.02), JNS: 14.57 (-0.61)

Why Janus Capital (JNS) Stock Is Up Today
at The Street - Thu Oct 23, 11:19AM CDT
Shares of Janus Capital (JNS) are higher after reporting that 2014 third-quarter profits rose 25% on higher assets.
JNS: 14.57 (-0.61)

Janus Capital (JNS) Approaches New Upside Target of $15.01
Comtex SmarTrend(R) - Thu Oct 23, 9:30AM CDT
Shares of Janus Capital (NYSE:JNS) opened today above their pivot of $14.42 and have already reached the first level of resistance at $14.64. Analysts will be watching for a cross of the next upside pivot targets of $15.01 and $15.60.
JNS: 14.57 (-0.61)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aurra Markets Wins 'Most Transparent Broker' Award 2026

Updated Category News Views 1

Spotlight on Transparency in Trading Alright, so Aurra Markets snagged the 'Most Transparent Broker' award at the Money Expo in Mumbai this year. From the greasy streets of trading floors to the polished halls of Jio World Convention Centre, transparency is one of those golden words you hear tossed around, but like finding a needle in a haystack, it’s not always easy to...

Continue Reading
Spencer Spirit Completes Hot Topic Acquisition

Updated Category News Views 1

Merging Forces in Retail In the latest retail reshuffle, Spencer Spirit Holdings has wrapped up its acquisition of Hot Topic, Inc., alongside its eclectic sub-brands: BoxLunch and Her Universe. This move doubles down on Spencer Spirit's ambitions to tighten its grip on the mall-based specialty retail game. If you're an investor looking for a shake-up that could redefine...

Continue Reading
Codoxo Snags 2026 Award for AI Payment Innovation

Updated Category News Views 2

Revolutionizing Healthcare Payment with AI Ah, healthcare and payments—two things that can make even the most patient folks lose their cool. But here comes Codoxo, shaking up this landscape with its Point Zero Payment Integrity solution, and someone's finally giving them the nod they deserve. For those of us who have been in the game for a while, this announcement is...

Continue Reading
ITP Media's Bold Move: Ready for Asian Market Surge

Updated Category News Views 1

Pushing Boundaries: ITP Media Group Eyes Asia ITP Media Group isn't here to tiptoe around the media market; they're diving headfirst with the recent takeover of Heart Media Group. A bold move, some might say, in this volatile world of media mergers and acquisitions. But let's break down what this really means. A Strategic Bet on Luxury To start, ITP Media is beefing up...

Continue Reading
XTransfer Revs Up Expansion in the UAE Market

Updated Category News Views 1

In the nitty-gritty world of B2B payments, securing a spot in a powerhouse like the UAE is no small potatoes. XTransfer just snagged an in-principle nod from the UAE Central Bank for a Retail Payment Services Licence, and that's got to feel like sweet validation for a company that's aggressively pushing its regulatory map beyond corners it's already conquered. Eyeing the...

Continue Reading
Immunic Pushes Boundaries in MS with Vidofludimus

Updated Category News Views 2

Shaking Things Up in Multiple Sclerosis Therapy There's no telling how often the biotech sector tosses around the term 'game-changer,' but when Immunic's name comes up, more ears are perking up these days. The New York-based firm, waving the Nasdaq: IMUX flag, is lining up a virtual shindig come September 9, 2026, and for anyone invested in multiple sclerosis (MS) or...

Continue Reading
GoPro's $1.14 Buyout Scrutinized: Fair Value Debate

Updated Category News Views 2

Unpacking the GoPro Buyout Announcement There's some commotion brewing in the investor world, especially if you're clutching onto shares of GoPro (NASDAQ:GPRO). A $1.14 per share buyout has hit the spotlight, and folks are asking if this deal is kosher, particularly when there's $285 million on the line. Does the price truly reflect what GoPro's worth? Ademi LLP is...

Continue Reading
Epson and STOPware Reinvent Visitor Badges for Security

Updated Category News Views 12

Gone are the days when a flimsy monochrome badge was all that stood between a visitor and unrestricted access. Today, Epson and STOPware rock the boat with their new collaboration, offering a game-changing approach to security with full-color badge printing. This isn't just a vanity upgrade; it's about real security enhancement creating immediate visual cues. Shifting the...

Continue Reading
GenesisFX Rolls Out Live Leaderboards, Boosts Social Trading

Updated Category News Views 5

Traders buckle up! GenesisFX Markets just kicked open a new chapter in forex and CFD trading with their Live Leaderboards and beefed-up social trading tools. What's the commotion about? Well, that's your hook. These leaderboards are the newest addition to their ecosystem, paired with some serious social trading muscle. As Arkadiusz Bujalski, the Head of Ops and System...

Continue Reading
stackArmor Secures FedRAMP High: A Strategic Milestone

Updated Category News Views 2

stackArmor: Carving a Niche in Federal Cybersecurity Hey, not every day you wake up to find a company carving its niche in federal cybersecurity quite the way stackArmor is doing. They've recently got their hands on that elusive FedRAMP High authorization for The Armory. What's this mean in English? Well, for starters, these guys are showing they're serious about...

Continue Reading

Top 5 Most Recently Viewed Articles

Roche's Evrysdi Tablet Revolutionizes SMA Treatment Options

Updated Category News Views 195

Roche's Evrysdi Tablet Revolutionizes SMA Treatment Options Roche has recently made a remarkable advancement in the field of spinal muscular atrophy (SMA) treatment with the approval of the Evrysdi® tablet by the European Commission. This new formulation is not just another medication; it symbolizes a significant leap towards enhancing the quality of life for individuals...

Continue Reading
IVX Health Celebrates Recognition as Top Workplace in Healthcare

Updated Category News Views 138

IVX Health Honored by Modern Healthcare IVX Health has been recognized by Modern Healthcare as one of the Best Places to Work in Healthcare for 2024. This esteemed honor reflects the company's commitment to excellence within the healthcare sector. The annual program highlights 150 distinguished organizations that excel in fostering a supportive and engaging workplace, and...

Continue Reading
NAMI Strengthens Leadership to Address Mental Health Challenges

Updated Category News Views 174

New Board Leadership at the National Alliance on Mental Illness The National Alliance on Mental Illness (NAMI) has announced significant changes in its leadership to tackle the growing mental health crisis in the United States. This newly elected board for the 2025-2026 term comprises dedicated individuals with personal and community ties to mental health advocacy,...

Continue Reading
In-Depth Insights into Depression Treatment Market Trends

Updated Category News Views 208

Overview of the Depression Treatment Market The depression treatment market is seeing a notable surge fueled by increasing mental health awareness and a rising number of individuals affected by this serious condition. With over 280 million people globally struggling with depression, the ongoing advancements in treatment options, including innovative antidepressants and...

Continue Reading